Posted on 4/4/19
Osiris Therapeutics Is Undervalued In Buyout
Summary While Osiris Therapeutics has appreciated 40% this year to $19, it is still undervalued. We forecast sales to rise greater than 20% in 2019, after . . .
Posted on 4/4/19
Osiris Therapeutics Is Undervalued In Buyout
SummaryWhile Osiris Therapeutics has appreciated 40% this year to $19, it is still undervalued.We forecast sales to rise greater than 20% in 2019, after a 20% . . .
Posted on 4/10/18
Osiris Therapeutics: Regenerated
Located in Columbia, Md., Osiris Therapeutics (NASDAQ:OSIR) is a leader in regenerative medicine. Osiris is currently re-emerging from a turbulent period of time of delayed financials, . . .
Posted on 12/8/17
Osiris Therapeutics: Expecting Better In 2018
What Is Osiris Therapeutics?Osiris Therapeutics (NASDAQ:OSIR) spun out of Case Western Reserve University in 1992 to leverage stem cell technology discovered by Dr. Arnold Caplan and . . .
Washington DC
